T. Rowe Price Associates’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

T. Rowe Price Associates’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	–	–	1393
2022 Q3	–	Sell	-125,242	Closed	-$3.58M	–	1356
2022 Q2	$4.04M	Sell	125,242 -1,554	-1%	-$58.6K	﹤0.01%	1450
2022 Q1	$5.17M	Sell	126,796 -7,127	-5%	-$299K	﹤0.01%	1464
2021 Q4	$5.96M	Buy	133,923 +5,871	+5%	+$282K	﹤0.01%	1474
2021 Q3	$6.37M	Sell	128,052 -123	-0.1%	-$6.41K	﹤0.01%	1480
2021 Q2	$6.86M	Sell	128,175 -11,330	-8%	-$569K	﹤0.01%	1461
2021 Q1	$6.37M	Buy	139,505 +1,264	+0.9%	+$60.7K	﹤0.01%	1442
2020 Q4	$6.72M	Sell	138,241 -103,433	-43%	-$4.94M	﹤0.01%	1402
2020 Q3	$10.7M	Sell	241,674 -55,095	-19%	-$2.33M	﹤0.01%	1286
2020 Q2	$11.5M	Sell	296,769 -581,066	-66%	-$23.5M	﹤0.01%	1267
2020 Q1	$36.2M	Buy	+877,835	New	+$42M	0.01%	893

Other funds holding ELAT

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Bluefin Capital Management New York $156M AUM 18.42% 1-Year Est. Return

T. Rowe Price Associates's ELAT Position: Q4 2022 in Review

T. Rowe Price Associates held its Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) position steady in Q4 2022 at 0 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1393.

T. Rowe Price Associates first reported a position in ELAT in Q1 2020 and has held it in 10 quarters since. The position peaked at $36.2M in Q1 2020. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

T. Rowe Price Associates held 0 shares of Elanco Animal Health Incorporated 5.00% Tangible Equity Units worth $2.45M as of Q4 2022.
T. Rowe Price Associates left its Elanco Animal Health Incorporated 5.00% Tangible Equity Units share count unchanged in Q4 2022.
Elanco Animal Health Incorporated 5.00% Tangible Equity Units made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q4 2022, its #1393 holding.
T. Rowe Price Associates first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and has held it in 10 quarters since.
T. Rowe Price Associates's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $36.2M in Q1 2020.
27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.